| Identification | Back Directory | [Name]
BIFEMELANE | [CAS]
90293-01-9 | [Synonyms]
E-0687
Alnert
Celeport
MCI-2016
BIFEMELANE
BIFEMELANE USP/EP/BP
4-(2-BENZYLPHENOXY)-N-METHYLBUTYLAMINE
4-(O-Benzylphenoxy)-N-methylbutylamine
N-Methyl-4-(2-benzylphenoxy)butylamine
4-(2-Benzylphenoxy)-N-Methylbutan-1-aMine
N-Methyl-4-[(2-benzylphenyl)oxy]butan-1-amine
N-Methyl-4-[2-(phenylmethyl)phenoxy]-1-butanamine
4-(2-Benzylphenoxy)-N-methylbutylaminehydrochloride
1-Butanamine, N-methyl-4-[2-(phenylmethyl)phenoxy]- | [Molecular Formula]
C18H23NO | [MDL Number]
MFCD00661085 | [MOL File]
90293-01-9.mol | [Molecular Weight]
269.38 |
| Hazard Information | Back Directory | [Chemical Properties]
Bifemelane Hydrochloride: C????H????NO??HCl [62232-46-6]. White crystalline powder, odorless, bitter. Hygroscopic. Freely soluble in chloroform, methanol, ethanol, glacial acetic acid, or water, slightly soluble in anhydrous ethanol, poorly soluble in anhydrous acetic acid or acetone, and practically insoluble in ether. Melting point: 117-121°C. Acute toxicity LD50 in mice and rats (mg/kg): 1000, 1080 mg/kg orally; 173, 130 mg/kg intraperitoneally. | [Originator]
Bifemelane
hydrochloride,ABATRA Technology
Co., Ltd. | [Definition]
ChEBI: N-methyl-4-[2-(phenylmethyl)phenoxy]-1-butanamine is a diarylmethane. | [Manufacturing Process]
N-Methyl-4-[2-(phenylmethyl)phenoxy]-1-butanamine was prepared from 2-
(5-bromopentyloxy)diphenylmethane and of methylamine in ethanol is at
50°C in a sealed tube (heating for 3 hours). Ethanol and excess methylamine
are distilled in vacuo, 2 N NaOH aqueous solution is added, and the reaction
product is extracted with ether. Dry hydrogen chloride gas is passed into the
ether solution, and the precipitate collected by filtration. Recrystallization from
ethanol-ether gives N-methyl-4-[2-(phenylmethyl)phenoxy]-1-butanamine
hydrochloride, m.p. 87.5-89.5°C. | [Therapeutic Function]
Antidepressant, Antiulcer, Nootropic | [Biological Activity]
Antidepressant MAO inhibitor. Reverses catalepsy induced by tetrabenazine in mice and increases locomotor activity in MPTP-treated marmosets. |
|
|